Private Label OTC Giant Stretches For Switch Help

Perrigo Will Pay $2.1Bn In Cash Deal For HRA Pharma

HRA brings needed expertise in OTC switches to Perrigo, which regularly is first to launch generic equivalents for brand switches but its name hasn’t been linked to submitting proposals for making additional drug ingredients available OTC.

• Source: Alamy

Perrigo Company PLC’s planned acquisition of French firm HRA Pharma will not only bring additional products and markets, but also enhance the private label OTC giant’s outlook for being first in the US to introduce additional nonprescription ingredients. 

HRA, officially identified in France as Hera SAS, brings needed expertise in OTC switches to Perrigo, which is regularly is...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Deals

More from Business